𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Restless legs syndrome: Diagnostic assessment and the advantages and risks of dopaminergic treatment

✍ Scribed by Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder

Publisher
Springer
Year
2006
Tongue
English
Weight
231 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Normal dopaminergic and serotonergic met
Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients
✍ Karin Stiasny-Kolster; J. Carsten Möller; Johannes Zschocke; Oliver Bandmann; We 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

Cerebrospinal fluid (CSF) and blood obtained from 22 untreated or scarcely treated patients with moderate to severe restless legs syndrome (RLS; mean age, 58.6 +/- 13 years) and 11 control subjects (mean age, 56.6 +/- 12.9 years) were investigated for biogenic amines between 6:00 and 8:00 PM. We did

State of the art in restless legs syndro
State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome
✍ Wolfgang H. Oertel; Claudia Trenkwalder; Marco Zucconi; Heike Benes; Diego Garci 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot

Treatment of restless legs syndrome with
Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine
✍ Frithjof Tergau; Stephan Wischer; Christian Wolf; Walter Paulus 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

## Abstract An open pilot study with the dopamine agonist α‐dihydroergocryptine (DHEC) was conducted in 16 patients with idiopathic restless legs syndrome (RLS) over a period of 5 weeks. Following a drug‐free interval of 1 week, the patients were treated with daily doses of 10 to 40 mg DHEC. As com

Augmentation of restless legs syndrome w
Augmentation of restless legs syndrome with long-term tramadol treatment
✍ Roberto Vetrugno; Chiara La Morgia; Roberto D'Angelo; Daniela Loi; Federica Prov 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

## Abstract Restless legs syndrome (RLS) augmentation, defined as a kind of suppression of the circadian rhythm of the disease in which sensory and motor symptoms appear earlier during the day (and over previously unaffected body parts), with a progressive phase advance until, backwards, the sympto